|
시장보고서
상품코드
1807686
ㄴ세계의 포스트바이오틱스 시장 규모, 점유율, 동향, 업계 분석 : 형상별, 유형별, 유통 채널별, 지역별 - 시장 예측(2025-2034년)Postbiotics Market Size, Share, Trends, Industry Analysis Report By Form (Powder, Capsules, Liquid, Tablets, and Others), By Type, By Distribution Channel, and By Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면 포스트바이오틱스 시장 규모는 2034년까지 3억 1,066만 달러에 달할 전망입니다. 이 조사 리포트는 현재 시장 역학의 상세 인사이트와 향후 시장 성장에 관한 분석을 제공하고 있습니다.
포스트바이오틱스는 프로바이오틱스와 관련된 생존성 문제 없이 장 건강 개선, 면역 조절 강화, 대사 지원 등 과학적으로 검증된 효능을 제공하면서 예방의학 및 영양학의 기능성 성분으로 부상하고 있습니다.
안전하고 안정적이며 지속가능한 건강 솔루션에 대한 소비자 수요 증가, 건강기능식품, 기능성 식품, 의약품에 대한 적용 증가, 제형 유연성 및 규제 준수를 개선하는 지속적인 기술 혁신으로 인해 시장이 크게 성장하고 있습니다.
포스트바이오틱스 시장 : 분석 개요
형태별로는 안정성, 제형화 용이성, 기능성 식품, 식품 및 음료, 건강보조식품과의 높은 적합성으로 인해 분말 부문이 2024년 시장을 주도했습니다.
유형별로는 단쇄 지방산(SCFA)이 2024년 가장 큰 점유율을 차지했습니다. 이는 장 건강 유지, 신진대사 조절, 염증 억제에 대한 역할이 임상적으로 검증되었기 때문입니다.
유통 채널 측면에서는 2024년 온라인 소매가 큰 비중을 차지했습니다. 이는 다양한 건강 제품을 제공하는 E-Commerce 플랫폼에 대한 선호도 증가, 정기 구매 모델, 택배의 편리성 등에 힘입은 것입니다.
아시아태평양은 중국, 인도, 동남아시아의 건강 및 웰빙에 대한 인식이 높아짐에 따라 2024년 압도적인 점유율을 차지했습니다.
북미는 소화기 건강 및 면역력 강화를 위한 기능성 식품 및 건강기능식품에 대한 소비자의 강력한 수요로 인해 CAGR이 가장 빠르게 성장할 것으로 예측됩니다.
세계 시장의 주요 기업에는 Archer-Daniels-Midland Company, BASF SE, Beekeeper's Naturals, Inc., Bioflag Group, Cargill, Incorporated, DSM-Firmenich AG, Essential Formulas Incorporated, Glac Biotech Co.Ltd., Ildong Pharmaceutical Co.Ltd., Kerry Group plc, Kemin Industries, Inc., MCLS Europe B.V., Phileo by Lesaffre, Sabinsa Corporation, POSTBIOTICA S.R.L. 등이 있습니다.
목차
제1장 서론
제2장 개요
제3장 분석 방법
제4장 세계의 포스트바이오틱스 시장 인사이트
- 시장 스냅숏
- 포스트바이오틱스 시장 역학
- 촉진요인과 기회
- 생활습관병의 증가가 포스트바이오틱스의 도입을 촉진
- 고령화 사회에서 면역·소화기계 건강 솔루션의 수요 증가
- 억제요인과 과제
- 고액의 연구개발비와 임상 검증비
- 촉진요인과 기회
- PESTLE 분석
- 포스트바이오틱스 시장의 동향
- 밸류체인 분석
제5장 세계의 포스트바이오틱스 시장 : 형상별
- 주요 분석 결과
- 서론
- 분말
- 캡슐
- 액체
- 정제
- 기타
제6장 세계의 포스트바이오틱스 시장 : 유형별
- 주요 분석 결과
- 서론
- 단쇄지방산
- 리포 다당류
- Muramly dipeptide
- 인돌
- 테이코산
- 락토스 핀
- P40 분자
제7장 세계의 포스트바이오틱스 시장 : 유통 채널별
- 주요 분석 결과
- 서론
- 온라인 소매
- 슈퍼마켓/하이퍼마켓
- 드러그스토어
- 소매점
- 편의점
- 기타
제8장 세계의 포스트바이오틱스 시장 : 지역별
- 주요 분석 결과
- 서론
- 포스트바이오틱스 시장 분석 : 지역별(2020-2034년)
- 북미
- 북미 : 형상별(2020-2034년)
- 북미 : 유형별(2020-2034년)
- 북미 : 유통 채널별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 형상별(2020-2034년)
- 유럽 : 유형별(2020-2034년)
- 유럽 : 유통 채널별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 형상별(2020-2034년)
- 아시아태평양 : 유형별(2020-2034년)
- 아시아태평양 : 유통 채널별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 형상별(2020-2034년)
- 중동 및 아프리카 : 유형별(2020-2034년)
- 중동 및 아프리카 : 유통 채널별(2020-2034년)
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 형상별(2020-2034년)
- 라틴아메리카 : 유형별(2020-2034년)
- 라틴아메리카 : 유통 채널별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제9장 경쟁 구도
- 사업 확대·기업 인수 분석
- 사업 확대
- 기업 인수
- 제휴/협업/합의/공개
제10장 기업 개요
- Archer-Daniels-Midland Company
- BASF SE
- Beekeeper's Naturals, Inc.
- Bioflag Group
- Cargill, Incorporated
- DSM-Firmenich AG
- Essential Formulas Incorporated
- Glac Biotech Co., Ltd.
- Ildong Pharmaceutical Co., Ltd.
- Kerry Group plc
- Kemin Industries, Inc.
- MCLS Europe B.V.
The postbiotics market size is expected to reach USD 310.66 Million by 2034, according to a new study by Polaris Market Research. The report "Postbiotics Market Size, Share, Trends, Industry Analysis Report By Form (Powder, Capsules, Liquid, Tablets, and Others), By Type, By Distribution Channel, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Postbiotics are emerging as functional ingredients in preventive healthcare and nutrition, offering scientifically validated benefits such as improved gut health, enhanced immune modulation, and metabolic support without the viability challenges associated with probiotics.
The market is growing significantly due to the rising consumer demand for safe, stable, and sustainable health solutions, increasing application in dietary supplements, functional foods, and pharmaceuticals, and continuous innovations that improve formulation flexibility and regulatory compliance.
Postbiotics Market Report Highlights
Based on form, the powder segment dominated the market in 2024, due to its stability, ease of formulation, and high compatibility with functional foods, beverages, and dietary supplements.
Based on type, short-chain fatty acids (SCFAs) held the largest share in 2024, owing to clinically validated role in maintaining gut health, regulating metabolism, and reducing inflammation.
In terms of distribution channel, online retail accounted for a significant share in 2024, fueled by the growing preference for e-commerce platforms offering a wide range of health products, subscription models, and home delivery convenience.
Asia Pacific accounted for a dominant share in 2024, supported by rising health and wellness awareness across China, India, and Southeast Asia.
North America is projected to grow at the fastest CAGR, attributed to strong consumer demand for functional foods and dietary supplements targeting digestive health and immune support.
Key players in the global market include Archer-Daniels-Midland Company, BASF SE, Beekeeper's Naturals, Inc., Bioflag Group, Cargill, Incorporated, DSM-Firmenich AG, Essential Formulas Incorporated, Glac Biotech Co., Ltd., Ildong Pharmaceutical Co., Ltd., Kerry Group plc, Kemin Industries, Inc., MCLS Europe B.V., Phileo by Lesaffre, Sabinsa Corporation, and POSTBIOTICA S.R.L.
Polaris Market Research has segmented the market report based on form, type, distribution channel, and region:
By Form Outlook (Revenue, USD Million, 2020-2034)
Powder
Capsules
Liquid
Tablets
Others
By Type Outlook (Revenue, USD Million, 2020-2034)
Short-chain fatty acids
Lipopolysaccharides
Muramly dipeptide
Indole
Teichoic acid
Lactose Pin
P40 molecule
By Distribution Channel Outlook (Revenue, USD Million, 2020-2034)
Online Retail
Supermarkets/Hypermarkets
Drug Stores
Retail Stores
Convenience Store
Others
By Regional Outlook (Revenue, USD Million, 2020-2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Postbiotics Market Insights
- 4.1. Postbiotics Market - Market Snapshot
- 4.2. Postbiotics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Prevalence of Lifestyle Disorders Driving Adoption of Postbiotics
- 4.2.1.2. Aging Population Increasing Demand for Immunity and Digestive Health Solutions
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High R&D and Clinical Validation Costs
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Postbiotics Market Trends
- 4.6. Value Chain Analysis
5. Global Postbiotics Market, by Form
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Postbiotics Market, by Form, 2020-2034 (USD Million)
- 5.3. Powder
- 5.3.1. Global Postbiotics Market, by Powder, by Region, 2020-2034 (USD Million)
- 5.4. Capsules
- 5.4.1. Global Postbiotics Market, by Capsules, by Region, 2020-2034 (USD Million)
- 5.5. Liquid
- 5.5.1. Global Postbiotics Market, by Liquid, by Region, 2020-2034 (USD Million)
- 5.6. Tablets
- 5.6.1. Global Postbiotics Market, by Tablets, by Region, 2020-2034 (USD Million)
- 5.7. Others
- 5.7.1. Global Postbiotics Market, by Others, by Region, 2020-2034 (USD Million)
6. Global Postbiotics Market, by Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Postbiotics Market, by Type, 2020-2034 (USD Million)
- 6.3. Short-chain fatty acids
- 6.3.1. Global Postbiotics Market, by Short-chain fatty acids, by Region, 2020-2034 (USD Million)
- 6.4. Lipopolysaccharides
- 6.4.1. Global Postbiotics Market, by Lipopolysaccharides, by Region, 2020-2034 (USD Million)
- 6.5. Muramly dipeptide
- 6.5.1. Global Postbiotics Market, by Muramly dipeptide, by Region, 2020-2034 (USD Million)
- 6.6. Indole
- 6.6.1. Global Postbiotics Market, by Indole, by Region, 2020-2034 (USD Million)
- 6.7. Teichoic acid
- 6.7.1. Global Postbiotics Market, by Teichoic acid, by Region, 2020-2034 (USD Million)
- 6.8. Lactose Pin
- 6.8.1. Global Postbiotics Market, by Lactose Pin, by Region, 2020-2034 (USD Million)
- 6.9. P40 molecule
- 6.9.1. Global Postbiotics Market, by P40 molecule, by Region, 2020-2034 (USD Million)
7. Global Postbiotics Market, by Distribution Channel
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 7.3. Online Retail
- 7.3.1. Global Postbiotics Market, by Online Retail, by Region, 2020-2034 (USD Million)
- 7.4. Supermarkets/Hypermarkets
- 7.4.1. Global Postbiotics Market, by Supermarkets/Hypermarkets, by Region, 2020-2034 (USD Million)
- 7.5. Drug Stores
- 7.5.1. Global Postbiotics Market, by Drug Stores, by Region, 2020-2034 (USD Million)
- 7.6. Retail Stores
- 7.6.1. Global Postbiotics Market, by Retail Stores, by Region, 2020-2034 (USD Million)
- 7.7. Convenience Store
- 7.7.1. Global Postbiotics Market, by Convenience Store, by Region, 2020-2034 (USD Million)
- 7.8. Others
- 7.8.1. Global Postbiotics Market, by Others, by Region, 2020-2034 (USD Million)
8. Global Postbiotics Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Postbiotics Market Assessment, By Geography, 2020-2034 (USD Million)
- 8.3. Postbiotics Market - North America
- 8.3.1. North America: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.3.2. North America: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.3.3. North America: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.3.4. Postbiotics Market - U.S.
- 8.3.4.1. U.S.: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.3.4.2. U.S.: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.3.4.3. U.S.: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.3.5. Postbiotics Market - Canada
- 8.3.5.1. Canada: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.3.5.2. Canada: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.3.5.3. Canada: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4. Postbiotics Market - Europe
- 8.4.1. Europe: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.4.2. Europe: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.4.3. Europe: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.4. Postbiotics Market - UK
- 8.4.4.1. UK: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.4.4.2. UK: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.4.4.3. UK: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.5. Postbiotics Market - France
- 8.4.5.1. France: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.4.5.2. France: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.4.5.3. France: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.6. Postbiotics Market - Germany
- 8.4.6.1. Germany: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.4.6.2. Germany: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.4.6.3. Germany: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.7. Postbiotics Market - Italy
- 8.4.7.1. Italy: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.4.7.2. Italy: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.4.7.3. Italy: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.8. Postbiotics Market - Spain
- 8.4.8.1. Spain: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.4.8.2. Spain: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.4.8.3. Spain: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.9. Postbiotics Market - Netherlands
- 8.4.9.1. Netherlands: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.4.9.2. Netherlands: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.4.9.3. Netherlands: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.10. Postbiotics Market - Russia
- 8.4.10.1. Russia: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.4.10.2. Russia: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.4.10.3. Russia: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.11. Postbiotics Market - Rest of Europe
- 8.4.11.1. Rest of Europe: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.4.11.2. Rest of Europe: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.4.11.3. Rest of Europe: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5. Postbiotics Market - Asia Pacific
- 8.5.1. Asia Pacific: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.5.2. Asia Pacific: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.5.3. Asia Pacific: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.4. Postbiotics Market - China
- 8.5.4.1. China: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.5.4.2. China: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.5.4.3. China: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.5. Postbiotics Market - India
- 8.5.5.1. India: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.5.5.2. India: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.5.5.3. India: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.6. Postbiotics Market - Malaysia
- 8.5.6.1. Malaysia: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.5.6.2. Malaysia: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.5.6.3. Malaysia: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.7. Postbiotics Market - Japan
- 8.5.7.1. Japan: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.5.7.2. Japan: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.5.7.3. Japan: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.8. Postbiotics Market - Indonesia
- 8.5.8.1. Indonesia: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.5.8.2. Indonesia: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.5.8.3. Indonesia: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.9. Postbiotics Market - South Korea
- 8.5.9.1. South Korea: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.5.9.2. South Korea: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.5.9.3. South Korea: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.10. Postbiotics Market - Australia
- 8.5.10.1. Australia: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.5.10.2. Australia: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.5.10.3. Australia: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.11. Postbiotics Market - Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.5.11.2. Rest of Asia Pacific: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.5.11.3. Rest of Asia Pacific: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6. Postbiotics Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.6.2. Middle East & Africa: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.6.3. Middle East & Africa: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.4. Postbiotics Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.6.4.2. Saudi Arabia: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.6.4.3. Saudi Arabia: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.5. Postbiotics Market - UAE
- 8.6.5.1. UAE: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.6.5.2. UAE: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.6.5.3. UAE: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.6. Postbiotics Market - Israel
- 8.6.6.1. Israel: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.6.6.2. Israel: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.6.6.3. Israel: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.7. Postbiotics Market - South Africa
- 8.6.7.1. South Africa: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.6.7.2. South Africa: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.6.7.3. South Africa: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.8. Postbiotics Market - Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.6.8.2. Rest of Middle East & Africa: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.6.8.3. Rest of Middle East & Africa: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.7. Postbiotics Market - Latin America
- 8.7.1. Latin America: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.7.2. Latin America: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.7.3. Latin America: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.7.4. Postbiotics Market - Mexico
- 8.7.4.1. Mexico: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.7.4.2. Mexico: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.7.4.3. Mexico: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.7.5. Postbiotics Market - Brazil
- 8.7.5.1. Brazil: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.7.5.2. Brazil: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.7.5.3. Brazil: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.7.6. Postbiotics Market - Argentina
- 8.7.6.1. Argentina: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.7.6.2. Argentina: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.7.6.3. Argentina: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.7.7. Postbiotics Market - Rest of Latin America
- 8.7.7.1. Rest of Latin America: Postbiotics Market, by Form, 2020-2034 (USD Million)
- 8.7.7.2. Rest of Latin America: Postbiotics Market, by Type, 2020-2034 (USD Million)
- 8.7.7.3. Rest of Latin America: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Archer-Daniels-Midland Company
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Form Benchmarking
- 10.1.4. Recent Development
- 10.2. BASF SE
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Form Benchmarking
- 10.2.4. Recent Development
- 10.3. Beekeeper's Naturals, Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Form Benchmarking
- 10.3.4. Recent Development
- 10.4. Bioflag Group
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Form Benchmarking
- 10.4.4. Recent Development
- 10.5. Cargill, Incorporated
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Form Benchmarking
- 10.5.4. Recent Development
- 10.6. DSM-Firmenich AG
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Form Benchmarking
- 10.6.4. Recent Development
- 10.7. Essential Formulas Incorporated
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Form Benchmarking
- 10.7.4. Recent Development
- 10.8. Glac Biotech Co., Ltd.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Form Benchmarking
- 10.8.4. Recent Development
- 10.9. Ildong Pharmaceutical Co., Ltd.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Form Benchmarking
- 10.9.4. Recent Development
- 10.10. Kerry Group plc
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Form Benchmarking
- 10.10.4. Recent Development
- 10.11. Kemin Industries, Inc.
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Form Benchmarking
- 10.11.4. Recent Development
- 10.12. MCLS Europe B.V.
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Form Benchmarking
- 10.12.4. Recent Development
